• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The Effect of Arterial PaCO2 in COPD Exacerbations with and without Peripheral Edema.

作者信息

Rezaeetalab Fariba, Zeraatti Abbas Ali, Sharifipour Farzaneh, Davoodi Rozita, Pourzand Hoorak

出版信息

Rom J Intern Med. 2015 Oct-Dec;53(4):343-7. doi: 10.1515/rjim-2015-0044.

DOI:10.1515/rjim-2015-0044
PMID:26939211
Abstract

INTRODUCTION

Studies often suggest hypoxemia is an important factor for sodium retention in chronic obstructive pulmonary disease (COPD), although hypercapnia is also associated with sodium retention in these patients. Hence, we have presented the major role of PaCO(2) in edema due to COPD.

METHOD

COPD patients who were hospitalized due to exacerbation were enrolled in the study and divided into two groups: with and without edema. Exclusion criteria included primary hepatic diseases, nephrotic syndrome and other renal diseases, left heart failure, or using drugs that would interfere with these organs or endocrine function. Data were coded and analyzed by SPSS software. Arterial blood gas variables including bicarbonate, pH, and PaO(2), PaCO(2) and O(2) saturation, and FEV1, FVC, FEV1/FVC were measured and compared between the groups.

RESULTS

No significant difference was found between the averages of bicarbonate, pH, PaO(2), 02 saturation, FEV1, FVC and FEV1/FVC in COPD in the two groups. PaCO(2) levels were significantly higher in patients with edema, compared to those without edema (p = 0.05). A reverse and significant correlation between PaCo(2) and FEV1 levels (p = 0.03) (r = -0.501) was observed in patients with edema.

CONCLUSION

This study suggests that hypercapnia is a major factor in causing edema in COPD patients compared to hypoxemia.

摘要

相似文献

1
The Effect of Arterial PaCO2 in COPD Exacerbations with and without Peripheral Edema.
Rom J Intern Med. 2015 Oct-Dec;53(4):343-7. doi: 10.1515/rjim-2015-0044.
2
Explained variance for blood gases in a population with COPD.慢性阻塞性肺疾病(COPD)患者群体中血气的解释方差
Clin Respir J. 2012 Apr;6(2):72-80. doi: 10.1111/j.1752-699X.2011.00248.x. Epub 2011 Aug 3.
3
Role of arterial blood gas abnormalities in oedema formation in COPD.
Respirology. 2004 Nov;9(4):481-4. doi: 10.1111/j.1440-1843.2004.00614.x.
4
Respiratory response to carbon dioxide stimulation during low flow supplemental oxygen therapy in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者低流量补充氧气治疗期间对二氧化碳刺激的呼吸反应
J Formos Med Assoc. 2002 Sep;101(9):607-15.
5
[Difference between single hole exhalation valve and plateau exhalation valve when used in patients treated with BiPAP Vision ventilator for chronic obstructive pulmonary disease with hypercapnia].[在使用BiPAP Vision呼吸机治疗慢性阻塞性肺疾病伴高碳酸血症患者时,单孔呼气阀与平台呼气阀的差异]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Apr;23(4):216-9.
6
Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension.无创通气治疗伴有肺动脉高压的慢性高碳酸血症 COPD 急性加重期患者。
Eur Rev Med Pharmacol Sci. 2012 Feb;16(2):183-91.
7
Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)急性加重期的可逆性高碳酸血症
Eur Respir J. 1993 Oct;6(9):1353-6.
8
[Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].[沙丁胺醇和异丙托溴铵对稳定期慢性阻塞性肺疾病患者动脉血气的影响]
Tuberk Toraks. 2003;51(2):132-7.
9
[Study on hypoxemia during sleep in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者睡眠期间低氧血症的研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Jul;22(7):401-4.
10
[Efficacy of domiciliary noninvasive positive pressure ventilation in chronic obstructive pulmonary disease patients].
Nihon Kokyuki Gakkai Zasshi. 2008 Jun;46(6):432-7.